AMGN vs REGN
AMGN 与 REGN 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | AMGNAmgen Inc. | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| 市值 | $251.99B | — |
| 市盈率(TTM) | 29.0 | 20.5 |
| 市净率 | 21.56 | — |
| 市销率 | 6.9x | — |
| 股息率 | 2.03% | — |
| 营收 | $38.09B(TTM) | $16.90B(TTM) |
| 营收同比增长 | 10.0% | 1.0% |
| 净利润 | $8.74B(TTM) | $4.82B(TTM) |
| 净利同比增长 | 88.5% | 2.1% |
| 每股收益(稀释) | $16.10(TTM) | $45.24(TTM) |
| 息税前利润率 | 24.7% | 24.9% |
| 净资产收益率 | 66.0% | 13.4% |
| 投入资本回报率 | 15.1% | 9.2% |
| 一年总回报 | +62.9% | +41.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:AMGN vs REGN
| 指标 | AMGN | REGN |
|---|---|---|
| 期末价值 | $42.1K | $26.9K |
| 总回报 | +320.8% | +169.3% |
| 年化收益 (CAGR) | +14.9% | +10.1% |
| 波动率 | 25.1% | 32.3% |
| 夏普比率 | 0.51 | 0.33 |
| 索提诺比率 | 0.76 | 0.49 |
| 最大回撤 | -24.9% | -59.7% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)